To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation	Advanced Solid Tumors	Recruiting	Phase 2	2025-05-22		NCT05541822

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Abion Inc	1

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ajou University Hospital	Suwon	South Korea	37
Asan Medical Center	Seoul	South Korea	338
Boramae Medical Center	Dongjak	South Korea	1
Cancer Care of North Florida, PA (Lake City Cancer Care, LLC) - Medical Oncology	Lake City	United States	1
Chi Mei Hospital, Liouying	Tainan	Taiwan	3
China Medical University Hospital	Taichung	Taiwan	36
Chungbuk National University Hospital	Cheongju-si	South Korea	1
Gachon University Gil Medical Center	Incheon	South Korea	72
Gyeongsang National University Hospital	Jinju	South Korea	1
Kangbuk Samsung Hospital	Seoul	South Korea	45
Korea University Anam Hospital	Seoul	South Korea	13
Mid Florida Center	Orange City	United States	1
National Cancer Center	Goyang-si	South Korea	32
National Cheng Kung University Hospital	Tainan	Taiwan	135
National Taiwan University Cancer Center (NTUCC)	Taipei	Taiwan	1
National Taiwan University Hospital	Taipei	Taiwan	174
Samsung Medical Center	Seoul	South Korea	375
Seoul National University Bundang Hospital	Seongnam-si	South Korea	57
Severance Hospital	Sinchon-dong	South Korea	1
Taipei Veterans General Hospital	Taipei	Taiwan	62
The Catholic University of Korea St Vincents Hospital	Suwon	South Korea	1
The Catholic University of Korea, Seoul St Mary's Hospitals	Seoul	South Korea	1
The Henry Ford Cancer Institute	Detroit	United States	1
The University of Texas MD Anderson Cancer Center	Houston	United States	3

Clinical trials